HER2 and EGFR expression in cutaneous spindle squamous cell carcinoma

American Journal of Dermatopathology

Volumn 29, Issue 6, 2007, Pages 559-563

  Schlauder, Scott M ^a   Calder, Kenneth B ^a   Moody, Patricia ^a   Morgan, Michael B ^a,b,c  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c James A Haley Veterans' Hospital ^*  (United States)

Author keywords

EGFR; HER2; Skin; Spindle cell SCC; Squamous cell carcinoma

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ADULT; AGED; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; COMPUTER ANALYSIS; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SKIN CARCINOMA; SKIN METASTASIS; SPINDLE CELL CARCINOMA; SQUAMOUS CELL CARCINOMA;

AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 36448985668     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/DAD.0b013e318159bf95     Document Type: Article

References (30)

1. Bernstein SC, Lim KK, Brodland DG, et al. The many faces of squamous cell carcinoma. Dermatol Surg. 1996;22:243-254.
2. Kane CL, Keehn CA, Smithberger E, et al. Histopathology of cutaneous squamous cell carcinoma and its variants. Semin Cutan Med Surg. 2004;23:54-61.
3. Wenig B. Squamous cell carcinoma of the upper aerodigestive tract: precursors and problematic variants. Mod Pathol. 2002;15:229-254.
4. Khanna M, Fortier-Riberdy G, Dinehart SM, et al. Histopathologic evaluation of cutaneous squamous cell carcinoma: results of a survey among dermatopathologists. J Am Acad Dermatol. 2003;48:721-726.
5. Cassarino DS, DeRienzo DP, Barr RJ. Cutaneous squamous cell carcinoma: a comprehensive clinicopathologic classification. Part One. J Cutan Pathol. 2006;33:191-206.
6. Cassarino DS, DeRienzo DP, Barr RJ. Cutaneous squamous cell carcinoma: a comprehensive clinicopathologic classification. Part Two. J Cutan Pathol. 2006;33:261-279.
7. Strauss MJ. Spindle cell epidermoid carcinoma: report of five cases in patients who had never been exposed to roentgen rays. Arch Derm Syphilol. 1950;61:633-647.
8. Smith JL. Spindle cell squamous carcinoma. In: Graham JH, Johnson WC, Helwig EB, eds. Dermal Pathology. Hagerstown, Md: Harper and Row; 1972:631-635.
9. Martin HE, Stewart FW. Spindle cell epidermoid carcinoma. Am J Cancer. 1935;24:273-297.
10. Shimizu T, Izumi H, Oga A, et al. Epidermal growth factor receptor overexpression and genetic aberrations in metastatic squamous-cell carcinoma of the skin. Dermatology. 2001;202:203-206.
11. Lavrijsen APM, Tieben LM, Ponec M, et al. Expression of EGF receptor, involucrin, and cytokeratins in basal cell and squamous cell carcinoma of the skin. Arch Dermatol Res. 1989;28183:83-88.
12. Bauknecht T, Gross G, Hagedorn M. Epidermal growth factor receptors in different skin tumors. Dermatologica. 1985;171:16-20.
13. Ahmed NU, Ueda M, Ichihashi M. Increased level of erbB-2/neu/HER-2 protein in cutaneous squamous cell carcinoma. Br J Dermatol. 1997;136:908-912.
14. Johnson TM, Rowe DE, Nelson BR, et al. Squamous cell carcinoma of the skin (excluding lip and oral mucosa). J Am Acad Dermatol. 1992;26:467-484.
15. Miller AB, Weinstock MA. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol. 1994;30:774-778.
16. Dinehart SM, Nelson-Adesokan P, Cockerell C, et al. Metastatic cutanous squamous cell carcinoma derived from actinic keratosis. Cancer. 1997;79:920-923.
17. Haydon RC. Cutaneous squamous cell carcinoma and related lesions. Otolaryngol Clin N Am. 1993;26:57-71.
18. Gerhard P, Uwe-Frithjof H. Histologic subtyping and malignancy assessment of cutaneous squamous cell carcinoma. Dermatol Surg. 2000;26:521-530.
19. Flemming ID, Cooper JS, Hensen DE, et al. American Joint Committee on Cancer Manual for Staging of Cancer. 5th ed. Philadelphia, Pa: Lippincott Raven; 1997.
20. Sobin LH, Wittekind C, eds. TNM Classification of Malignant Tumors: International Union against Cancer. 5th ed. New York, NY: Wiley; 1997.
21. Afzelius LE, Gunnarsson M, Nordgren H. Guidelines for prophylactic radical lymphnode dissection in cases of carcinoma of the external ear. Head Neck Surg. 1980;2:361-365.
22. Immermann SC, Scanlon EF, Christ M, et al. Locally recurrent squamous cell carcinoma of the skin. Cancer. 1983;51:1537-1540.
23. Frierson H, Cooper PH. Prognostic factors in squamous cell carcinoma of the lower lip. Hum Pathol. 1986;17:346-354.
24. Friedman HI, Cooper PH, Wanebo HJ. Prognostic and therapeutic use of microstaging of cutaneous squamous cell carcinoma of the trunk and extremities. Cancer. 1985;56:1099-1105.
25. Broders AC. Practical points on the microscopic grading of carcinoma. NY State J Med. 1932;32:667.
26. Breuninger H, Black B, Rassner G. Microstaging of squamous cell carcinomas. Am J Clin Pathol. 1990;94:624-627.
27. Martin HE, Stewart FW. Spindle-cell epidermoid carcinoma. Am J Cancer. 1935;24:273-297.
28. Sigel JE, Skacel M, Bergfeld WF, et al. The utility of cytokeratin 5/6 in the recognition of cutaneous spindle cell squamous cell carcinoma. J Cutan Pathol. 2001;28:520-524.
29. Dotto JE, Glusac EJ. P63 is a useful marker for cutaneous spindle cell squamous cell carcinoma. J Cutan Pathol. 2006;33:413-417.
30. Maubec E, Duvillard P, Velasco V, et al. Emmunohistochemical analysis of EGFR and HER-2 in patients with metastatic squamous cell carcinoma of the skin. Anticancer Res. 2005;25:1205-1210.